Nexalin Technology Announces Abstract Accepted For Presentation At 2023 Military Health System Research Symposium Validating The Potential Of Its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device For The Treatment Of Mild Traumatic Brain Injury
Nexalin Technology Announces Abstract Accepted For Presentation At 2023 Military Health System Research Symposium Validating The Potential Of Its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device For The Treatment Of Mild Traumatic Brain Injury
Nexalin Technology 宣佈摘要已獲准在 2023 年軍事衛生系統研究研討會上發表，驗證其非侵入性、基於頻率的深腦刺激設備在治療輕度創傷性腦損傷方面的潛力
Nexalin 科技股份有限公司（“公司” 或 “Nexalin”）（納斯達克股票代碼：NXL，NXLIW）今天宣佈，該公司的摘要標題爲：“MEG Source Imaging揭示了使用Nexalin...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。